Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadriceps Strength Exercise Plus Infrapatellar Fat Pad Corticosteroid Injection for Knee Osteoarthritis
ChiCTR2500109267Phase 2Not yet recruiting
- Sponsor
- Hefei First People's Hospital
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of triamcinolone acetonide in knee osteoarthritis (OA) (3 arms), sponsored by Hefei First People's Hospital. Primary endpoint: WOMAC Functional Score. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2500109267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109267.